Please check your inbox to confirm your subscription.
You are successfully registered to our newsletter.
Contact us
* Mandatory Field
Please fill in the form below to download the White Paper and subscribe to our quarterly newsletter.Compila il form
per scaricare il white paper
* Mandatory Field* Campi obbligatori

Novartis at Milano Design Week with an experiential event

09-04-2019

AIM Group is the Novartis’s trusted partner for the experiential event proposed at the Milano Design Week focused on “re-design” migraine therapy

Novartis, for the first time ever, is present at the Milano Design Week with the “Reimagine medicine: Re-DESIGN Migraine” project, an Experiential itinerary to deep dive the migraine burden through welfare and design, with focus on innovation.

Migraine is not a “simple headache” but a strongly disabling neurological disease that affects millions of patients. The three steps experiential journey, brought to life in collaboration with the designer Davide Radaelli, includes:

  • the Experience room, designed to experiment in a truly immersive way some acoustic and visual over-stimulation effects similar to those of a migraine attack;
  • the Migraine Concept Room, an interpretation of the concept of the ideal place of isolation, comfort and protection in which to shelter during the attack;
  • the Migraine relief room, a room prototype, which Novartis offers as a tangible potential solution - small, functional, accessible and easily implemented in a business environment - for better management of attacks in the workplace.

The event, realised in collaboration with AIM Group,  is open to the public from Tuesday 9th April to Sunday 14th, from 9 am to 9 pm, at Torneria T8 – Via Tortona, 30 – Milano.

 

Do you want to be updated on our latest projects, events and the industry news and trends? Please, subscribe to our quarterly AIM Insights Newsletter by clicking here

Do you need any assistance with your next project?

Subscribe to our newsletter

Stay up to date! Subscribe to AIM Group newsletter.